Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
Author:
Affiliation:
1. VU LSC-EMBL Partnership Institute for Genome Editing Technologies, Life Sciences Center, Vilnius University, LT-10257 Vilnius, Lithuania
2. Institute of Biochemistry, Life Science Center, Vilnius University, LT-10257 Vilnius, Lithuania
Abstract
Funder
European Regional Development Fund
Publisher
MDPI AG
Subject
General Medicine
Link
https://www.mdpi.com/2073-4409/12/20/2466/pdf
Reference146 articles.
1. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012
2. CRISPR/Cas9 technology as a potent molecular tool for gene therapy;Karimian;J. Cell. Physiol.,2019
3. Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease;Jarrett;Sci. Rep.,2017
4. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo;Yin;Nat. Biotechnol.,2016
5. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms;Akinc;Mol. Ther.,2010
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3